XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 160 filers reported holding XENON PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $664 | +22.3% | 18,562 | +34.9% | 0.07% | -1.5% |
| Q4 2022 | $543 | -99.4% | 13,763 | +2.8% | 0.07% | +1016.7% |
| Q1 2016 | $94,000 | -69.1% | 13,384 | -64.6% | 0.01% | -60.0% |
| Q4 2015 | $304,000 | -44.2% | 37,791 | -42.7% | 0.02% | -44.4% |
| Q3 2015 | $545,000 | +42.3% | 65,941 | +98.4% | 0.03% | +80.0% |
| Q2 2015 | $383,000 | +85.0% | 33,244 | +170.3% | 0.02% | +87.5% |
| Q1 2015 | $207,000 | – | 12,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
| GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
| ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
| DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
| Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
| Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
| BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |